Newsroom | 72850 results

Sorted by: Latest

EnglishChemicals/PlasticsResearch
-

New Paper Offers Practical Roadmap for Using Real-World Data in FDA Drug Approvals and Label Expansions

BLUEBELL, Pa.--(BUSINESS WIRE)--Slipstream co-authors a new CPT paper with practical guidance for using real-world data in FDA drug approvals and label expansions....
-

Octant Announces First Patient Dosed in Phase 1b/2 Clinical Study of OCT-980 for the Treatment of Retinitis Pigmentosa

EMERYVILLE, Calif.--(BUSINESS WIRE)--Octant, Inc., a clinical-stage drug discovery company developing corrector therapies for protein misfolding diseases, today announced that the first patient has been dosed in its ongoing Phase 1/2 clinical study evaluating OCT-980, an investigational oral small molecule for the treatment of rhodopsin-associated autosomal dominant Retinitis Pigmentosa (RHO-adRP). RHO-adRP is an inherited retinal disease caused by mutations in the RHO gene, the most common for...
-

Celanese Announces Engineered Materials Price Increase

DALLAS--(BUSINESS WIRE)--Celanese Announces Engineered Materials Price Increase...
-

Boise Cascade Surpasses $1 Million in Support for St. Jude Children's Research Hospital

BOISE, Idaho--(BUSINESS WIRE)--Boise Cascade Company (“Boise Cascade” or the “Company”) (NYSE: BCC) today announced the results of its 2026 companywide philanthropic campaign supporting St. Jude Children's Research Hospital®. The company raised $494,128.56, reaching well over $1 million in total contributions since their annual campaign began in 2024. The month-long campaign was marked by grassroots efforts across Boise Cascade's 60+ locations in the U.S. and Canada. Every dollar raised will su...
-

Countable Labs Sets a New Standard in Molecular Testing for Hematologic Malignancy Clinical Applications

PALO ALTO, Calif.--(BUSINESS WIRE)--Countable Labs announces Ancora assays for molecular testing of hematologic malignancy, marking the company's entry into clinical markets....
-

In Honor of National Peripheral Artery Disease (PAD) Awareness Month, THE SAGE GROUP Comments on the Amputation Lottery

ATLANTA--(BUSINESS WIRE)--Peripheral Artery Disease amputations depend on who you are and where you live, The Amputation Lottery. Blacks and women are at higher risk....
-

No Two Loads Are Alike: Wabash to Highlight Application-Specific Tank Trailers at NTTC 2026

LAFAYETTE, Ind.--(BUSINESS WIRE)--Wabash (NYSE: WNC), a leader in end-to-end supply chain solutions for the transportation, logistics and infrastructure markets, will showcase application-specific tank trailer solutions, safety technology and lifecycle support at National Tank Truck Carriers’ 2026 Tank Truck Week, Sept. 27-30 in Oklahoma City. At booth #1239, Wabash will display three tank trailers, including a specialty chemical trailer, fleet chemical trailer and frame-and-cradle sanitary tra...
-

McCarty Family Farms, MVP Dairy and Cargill Invest in the Next Generation of Agriculture With New Interactive Dairy Nutrition Exhibits

REXFORD, Kan.--(BUSINESS WIRE)--McCarty Family Farms has opened a new interactive dairy nutrition exhibit at the Judy McCarty Dairy Learning Center in Rexford, Kansas, with support from the Cargill Cares Council. A companion exhibit is also open at the MVP Dairy Learning Center in Celina, Ohio. Together, the exhibits give students, families and community members a hands-on way to learn how animal nutrition supports cow health, dairy farm performance and milk quality.The two learning centers have...
-

Scientific Review Finds Ingredients in Head & Shoulders Shampoos – 1% Selenium Sulfide and 1% Zinc Pyrithione – As the Strongest Evidence-Based Option for Best Over-the-Counter Dandruff Control

CINCINNATI--(BUSINESS WIRE)--What is the best over-the-counter treatment for dandruff? Scientists from Head & Shoulders and dermatology experts reviewed evidence at the September 2026 Science of Skin Summit in Austin, TX, suggesting the best treatments must go beyond anti-fungal benefits to reduce scalp irritation and improve scalp’s health – providing sustained dandruff control over time. These three holistic benefits are uniquely found in Head & Shoulders’ proprietary shampoo collecti...
-

Commercial Demand for Microgravity Drug Discovery Accelerates as Exobiosphere and Voyager Add Two Missions to the ISS

DENVER & HOUSTON--(BUSINESS WIRE)--Voyager Technologies (NYSE: VOYG) and Exobiosphere today announced two additional research campaigns aboard the International Space Station, expanding an agreement that is turning commercial biotech research in microgravity into a recurring, schedulable service rather than a one-off opportunity. Exobiosphere’s Orbital High-Throughput Screening in Microgravity (OHTS) platform, a mid-deck-locker-class system for automated drug screening, is scheduled for install...